{
    "pmcid": "11285730",
    "qa_pairs": {
        "What method was used to isolate nanobodies from llamas in the study?": [
            "Phage display libraries",
            "Hybridoma technology",
            "Yeast surface display",
            "Bacterial expression systems"
        ],
        "What potential route of administration is suggested for nanobodies due to their small size and stability?": [
            "Nasal administration",
            "Intravenous injection",
            "Oral ingestion",
            "Topical application"
        ],
        "What specific mutations in the Omicron RBD are mentioned as affecting antibody binding and immune recognition?": [
            "E484A and N501Y",
            "D614G and K417N",
            "L452R and T478K",
            "P681R and Q493R"
        ],
        "Which nanobodies were identified with high affinity for the Omicron BA.1 RBD in the study?": [
            "A8, H6, and B5-5",
            "C1, D2, and E3",
            "F4, G5, and H7",
            "I8, J9, and K10"
        ],
        "Which nanobody binds directly at the ACE-2 interface, occluding the receptor binding site?": [
            "H6",
            "A8",
            "B5-5",
            "C7"
        ]
    }
}